Literature DB >> 14304238

A REVIEW OF 17 CASES OF CARCINOMA OF THE THYROID AND PHAEOCHROMOCYTOMA.

E D WILLIAMS.   

Abstract

The salient features of 15 cases of carcinoma of the thyroid and phaeochromocytoma taken from the literature and two personal cases are reviewed. The significant points noted are the frequency with which the adrenal tumours were bilateral, the frequency with which a family history of phaeochromocytoma (six cases) and thyroid carcinoma (four cases) was present, and the frequency with which the type of thyroid tumour was medullary carcinoma. In four of the 15 published cases the thyroid tumour was described as being medullary. Two personal cases both had medullary carcinoma of the thyroid, and this was also the type of thyroid carcinoma present in five of the published cases in which the thyroid histology was personally reviewed, making a total of 11 medullary carcinomas out of 17 cases. At least one other tumour was probably medullary, judging by the histological description. It is suggested that the association between phaeochromocytoma and thyroid carcinoma is specifically with medullary carcinoma of the thyroid. Both personal cases showed multiple neural tumours; and because of this and the association with phaeochromocytoma the possible neural origin of medullary carcinoma of the thyroid is briefly discussed. The occurrence in a few cases of parathyroid tumours has raised the possibility that these cases are related to the multiple endocrine adenoma syndrome. The dissimilarity between the cases with medullary carcinoma of the thyroid and phaeochromocytoma and those cases with ademonas involving pituitary, parathyroid, adrenal cortex and pancreatic islets is stressed. The term ;medullary tumour syndrome' is suggested as a convenient non-committal name for this association of medullary carcinoma of the thyroid with tumours of the adrenal medulla.

Entities:  

Keywords:  ADRENAL GLAND NEOPLASMS; CARCINOMA; GENETICS, HUMAN; NEOPLASM ETIOLOGY; PATHOLOGY; PHEOCHROMOCYTOMA; THYROID NEOPLASMS

Mesh:

Year:  1965        PMID: 14304238      PMCID: PMC472926          DOI: 10.1136/jcp.18.3.288

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  CARCINOMA OF THE THYROID IN CHILDREN.

Authors:  A B HAYLES; L M JOHNSON; O H BEAHRS; L B WOOLNER
Journal:  Am J Surg       Date:  1963-11       Impact factor: 2.565

2.  ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN.

Authors:  P WERMER
Journal:  Am J Med       Date:  1963-08       Impact factor: 4.965

3.  Histological differentiation between phaeochromyocytoma and melanoma of the suprarenal gland.

Authors:  J C DICK; G M RITCHIE; H THOMPSON
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

4.  Familial endocrine tumors; report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomas.

Authors:  P CUSHMAN
Journal:  Am J Med       Date:  1962-03       Impact factor: 4.965

5.  Familial thyroid cancer.

Authors:  G H FRIEDELL; R J CAREY; H ROSEN
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

6.  Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period.

Authors:  L B WOOLNER; O H BEAHRS; B M BLACK; W M McCONAHEY; F R KEATING
Journal:  Am J Surg       Date:  1961-09       Impact factor: 2.565

7.  Pheochromocytoma in the adult and in the child.

Authors:  D M HUME
Journal:  Am J Surg       Date:  1960-04       Impact factor: 2.565

8.  Phaeochromocytoma, diabetes, and glycosuria.

Authors:  P FREEDMAN; R MOULTON; M L ROSENHEIM; A G SPENCER; D A WILLOUGHBY
Journal:  Q J Med       Date:  1958-07

9.  PHEOCHROMOCYTOMA WITH DEMONSTRATION OF PRESSOR (ADRENALIN) SUBSTANCE IN THE BLOOD PREOPERATIVELY DURING HYPERTENSIVE CRISES.

Authors:  E Beer; F H King; M Prinzmetal
Journal:  Ann Surg       Date:  1937-07       Impact factor: 12.969

10.  An unusual case of pheochromocytoma with fatal outcome.

Authors:  N O ROTHERMICH
Journal:  Ann Intern Med       Date:  1952-01       Impact factor: 25.391

View more
  32 in total

Review 1.  The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review.

Authors:  J B Hazard
Journal:  Am J Pathol       Date:  1977-07       Impact factor: 4.307

Review 2.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 3.  Origins of ... familial cancer: histopathological perspectives.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

Review 4.  Adenomas and carcinomas of the canine and feline thyroid.

Authors:  I Leav; A L Schiller; A Rijnberk; M A Legg; P J der Kinderen
Journal:  Am J Pathol       Date:  1976-04       Impact factor: 4.307

5.  My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!

Authors:  Elizabeth G Grubbs; Robert F Gagel
Journal:  J Clin Endocrinol Metab       Date:  2015-07       Impact factor: 5.958

Review 6.  Multiple endocrine neoplasia.

Authors:  R A Decker; S A Wells
Journal:  Jpn J Surg       Date:  1989-11

Review 7.  Catecholamines--a symposium.

Authors: 
Journal:  Calif Med       Date:  1972-09

8.  Thyroid carcinoma and Cushing's syndrome. A report of two cases with a review of the common features of the "non-endocrine" tumours associated with Cushing's syndrome.

Authors:  E D Williams; A M Morales; R C Horn
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

Review 9.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

10.  Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid.

Authors:  E D Williams; C L Brown; I Doniach
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.